Company profile for RiboX Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Riboxx Therapeutics is dedicated to pioneering RNA-based therapies aimed at treating genetic diseases. We harness the power of RNA technology to develop novel, targeted treatments that address the root causes of complex disorders. By focusing on RNA modulation and innovative drug delivery systems, Riboxx aims to create transformative therapies with the potential to change the lives of patients suffering from genetic and rare d...
Riboxx Therapeutics is dedicated to pioneering RNA-based therapies aimed at treating genetic diseases. We harness the power of RNA technology to develop novel, targeted treatments that address the root causes of complex disorders. By focusing on RNA modulation and innovative drug delivery systems, Riboxx aims to create transformative therapies with the potential to change the lives of patients suffering from genetic and rare diseases. With a commitment to scientific excellence, we strive to push the boundaries of medicine and unlock new possibilities for better health outcomes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No. 15, Lane 388, Shengrong Road, Pudong New Area, Shanghai
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/ribox-therapeutics-announces-first-patient-dosed-in-phase-iiia-clinical-trial-of-rxrg001-the-first-circular-rna-therapy-for-the-treatment-of-radiation-induced-xerostomia-and-hyposalivation-302395477.html

PR NEWSWIRE
09 Mar 2025

https://www.prnewswire.com/news-releases/ribox-therapeutics-announces-fda-clearance-for-ind-application-of-rxrg001-the-first-circular-rna-therapy-for-the-treatment-of-radiation-induced-xerostomia-and-hyposalivation-302287539.html

PR NEWSWIRE
25 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty